| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 7.40e-07 | 5 | 85 | 3 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.48e-06 | 6 | 85 | 3 | GO:0016160 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.23e-05 | 120 | 85 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | chloride ion binding | 4.01e-05 | 16 | 85 | 3 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 7.83e-05 | 103 | 85 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.78e-04 | 5 | 85 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.76e-04 | 144 | 85 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | cadherin binding | 6.07e-04 | 339 | 85 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 9.61e-04 | 11 | 85 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 1.15e-03 | 12 | 85 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.28e-03 | 749 | 85 | 10 | GO:0005509 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 1.93e-06 | 50 | 85 | 5 | GO:0044331 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.59e-06 | 53 | 85 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 5.24e-06 | 61 | 85 | 5 | GO:0034332 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 6.64e-05 | 167 | 85 | 6 | GO:0007043 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.24e-04 | 187 | 85 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.33e-04 | 63 | 85 | 4 | GO:0007157 | |
| GeneOntologyCellularComponent | catenin complex | 1.82e-07 | 32 | 85 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | adherens junction | 2.52e-05 | 212 | 85 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.42e-04 | 137 | 85 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 3.52e-04 | 230 | 85 | 6 | GO:0019898 | |
| GeneOntologyCellularComponent | cell-cell junction | 6.62e-04 | 591 | 85 | 9 | GO:0005911 | |
| Domain | Cadherin_cytoplasmic-dom | 6.72e-08 | 25 | 81 | 5 | IPR000233 | |
| Domain | Cadherin_C | 6.72e-08 | 25 | 81 | 5 | PF01049 | |
| Domain | Catenin_binding_dom | 1.48e-07 | 29 | 81 | 5 | IPR027397 | |
| Domain | - | 1.48e-07 | 29 | 81 | 5 | 4.10.900.10 | |
| Domain | Glyco_hydro_b | 3.44e-05 | 15 | 81 | 3 | IPR013780 | |
| Domain | ELL | 5.56e-05 | 3 | 81 | 2 | PF10390 | |
| Domain | ELL_N | 5.56e-05 | 3 | 81 | 2 | IPR019464 | |
| Domain | Aamy_C | 1.11e-04 | 4 | 81 | 2 | SM00632 | |
| Domain | Alpha_amylase | 1.11e-04 | 4 | 81 | 2 | IPR006046 | |
| Domain | Cadherin_CS | 1.11e-04 | 109 | 81 | 5 | IPR020894 | |
| Domain | GRAM | 1.14e-04 | 22 | 81 | 3 | PF02893 | |
| Domain | GRAM | 1.14e-04 | 22 | 81 | 3 | IPR004182 | |
| Domain | CADHERIN_1 | 1.32e-04 | 113 | 81 | 5 | PS00232 | |
| Domain | Cadherin | 1.32e-04 | 113 | 81 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.37e-04 | 114 | 81 | 5 | PS50268 | |
| Domain | - | 1.37e-04 | 114 | 81 | 5 | 2.60.40.60 | |
| Domain | CA | 1.43e-04 | 115 | 81 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.49e-04 | 116 | 81 | 5 | IPR015919 | |
| Domain | Cadherin | 1.62e-04 | 118 | 81 | 5 | IPR002126 | |
| Domain | Alpha-amylase_C | 1.84e-04 | 5 | 81 | 2 | PF02806 | |
| Domain | A-amylase/branching_C | 1.84e-04 | 5 | 81 | 2 | IPR006048 | |
| Domain | ELL/occludin | 2.76e-04 | 6 | 81 | 2 | IPR031176 | |
| Domain | LysM_dom | 2.76e-04 | 6 | 81 | 2 | IPR018392 | |
| Domain | Occludin_ELL | 2.76e-04 | 6 | 81 | 2 | IPR010844 | |
| Domain | LYSM | 2.76e-04 | 6 | 81 | 2 | PS51782 | |
| Domain | LysM | 2.76e-04 | 6 | 81 | 2 | PF01476 | |
| Domain | Occludin_ELL | 2.76e-04 | 6 | 81 | 2 | PF07303 | |
| Domain | - | 2.76e-04 | 6 | 81 | 2 | 3.10.350.10 | |
| Domain | LysM | 2.76e-04 | 6 | 81 | 2 | SM00257 | |
| Domain | Tyr_Pase_AS | 2.85e-04 | 73 | 81 | 4 | IPR016130 | |
| Domain | Aamy | 3.85e-04 | 7 | 81 | 2 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 3.85e-04 | 7 | 81 | 2 | IPR006047 | |
| Domain | Alpha-amylase | 3.85e-04 | 7 | 81 | 2 | PF00128 | |
| Domain | Cadherin_pro | 3.85e-04 | 7 | 81 | 2 | PF08758 | |
| Domain | Cadherin_pro_dom | 5.11e-04 | 8 | 81 | 2 | IPR014868 | |
| Domain | Cadherin_pro | 5.11e-04 | 8 | 81 | 2 | SM01055 | |
| Domain | TYR_PHOSPHATASE_1 | 5.32e-04 | 86 | 81 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 5.56e-04 | 87 | 81 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 5.56e-04 | 87 | 81 | 4 | IPR000387 | |
| Domain | - | 6.87e-04 | 92 | 81 | 4 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 9.04e-04 | 99 | 81 | 4 | IPR029021 | |
| Domain | - | 1.63e-03 | 14 | 81 | 2 | 2.60.40.1180 | |
| Domain | Myotubularin-like_Pase_dom | 1.63e-03 | 14 | 81 | 2 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 1.63e-03 | 14 | 81 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 1.63e-03 | 14 | 81 | 2 | IPR030564 | |
| Domain | Myotub-related | 1.63e-03 | 14 | 81 | 2 | PF06602 | |
| Domain | GRAM | 2.14e-03 | 16 | 81 | 2 | SM00568 | |
| Domain | PTPc_motif | 2.14e-03 | 59 | 81 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.14e-03 | 59 | 81 | 3 | IPR003595 | |
| Domain | PI3/4_kinase_cat_dom | 2.72e-03 | 18 | 81 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.72e-03 | 18 | 81 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.72e-03 | 18 | 81 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.72e-03 | 18 | 81 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.72e-03 | 18 | 81 | 2 | PS00916 | |
| Domain | Semaphorin | 3.36e-03 | 20 | 81 | 2 | IPR027231 | |
| Domain | Znf_FYVE_PHD | 3.83e-03 | 147 | 81 | 4 | IPR011011 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.30e-06 | 40 | 68 | 5 | MM15060 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 3.28e-06 | 48 | 68 | 5 | MM15069 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 8.46e-06 | 58 | 68 | 5 | M11980 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 8.83e-06 | 9 | 68 | 3 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.72e-05 | 11 | 68 | 3 | M1091 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.62e-05 | 73 | 68 | 5 | MM15126 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 7.20e-05 | 90 | 68 | 5 | M820 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 9.79e-05 | 96 | 68 | 5 | MM14592 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.08e-04 | 98 | 68 | 5 | M39830 | |
| Pathway | REACTOME_DIGESTION | 1.77e-04 | 23 | 68 | 3 | M27790 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE | 2.27e-04 | 5 | 68 | 2 | MM14588 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE | 2.27e-04 | 5 | 68 | 2 | M26963 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.48e-04 | 117 | 68 | 5 | M19248 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 2.90e-04 | 121 | 68 | 5 | M39823 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 3.23e-04 | 28 | 68 | 3 | M27837 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 8.99e-04 | 155 | 68 | 5 | M522 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 1.01e-03 | 10 | 68 | 2 | MM1394 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.40e-03 | 46 | 68 | 3 | M48317 | |
| Pubmed | 2.28e-10 | 15 | 85 | 5 | 33833667 | ||
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 1.17e-09 | 20 | 85 | 5 | 7806582 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.78e-09 | 91 | 85 | 7 | 28558017 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 6.90e-09 | 10 | 85 | 4 | 2059658 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 8.78e-09 | 29 | 85 | 5 | 22036570 | |
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.08e-08 | 11 | 85 | 4 | 7493641 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 32697825 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.41e-08 | 3 | 85 | 3 | 21827821 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 30982860 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 15299664 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 12527308 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 22063648 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 25588701 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 2423416 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 2.80e-07 | 6 | 85 | 3 | 6608795 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 2.80e-07 | 6 | 85 | 3 | 2788608 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 2081604 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 15286789 | ||
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 3.40e-07 | 24 | 85 | 4 | 25126785 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 8879495 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 4.90e-07 | 7 | 85 | 3 | 11839813 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 12414807 | ||
| Pubmed | Two-hybrid analysis of human salivary mucin MUC7 interactions. | 1.17e-06 | 9 | 85 | 3 | 16203048 | |
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 10861224 | ||
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 27151949 | ||
| Pubmed | Salivary protein profiles are linked to bitter taste acceptance in infants. | 2.29e-06 | 11 | 85 | 3 | 24248522 | |
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 22102170 | ||
| Pubmed | 3.96e-06 | 13 | 85 | 3 | 9615235 | ||
| Pubmed | 4.62e-06 | 99 | 85 | 5 | 34161765 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 5.03e-06 | 14 | 85 | 3 | 20847152 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8247017 | ||
| Pubmed | Thermal injury activates the eEF2K-dependent eEF2 pathway in pediatric patients. | 5.90e-06 | 2 | 85 | 2 | 22269896 | |
| Pubmed | Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice. | 5.90e-06 | 2 | 85 | 2 | 32810756 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11171339 | ||
| Pubmed | A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses. | 5.90e-06 | 2 | 85 | 2 | 19221463 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12213630 | ||
| Pubmed | Post-training dephosphorylation of eEF-2 promotes protein synthesis for memory consolidation. | 5.90e-06 | 2 | 85 | 2 | 19823585 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28219410 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10662782 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 3693353 | ||
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 7.71e-06 | 16 | 85 | 3 | 17278136 | |
| Pubmed | Cadherins Interact With Synaptic Organizers to Promote Synaptic Differentiation. | 1.77e-05 | 3 | 85 | 2 | 29760652 | |
| Pubmed | Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis. | 1.77e-05 | 3 | 85 | 2 | 29024627 | |
| Pubmed | EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. | 1.77e-05 | 3 | 85 | 2 | 11418481 | |
| Pubmed | Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma. | 1.77e-05 | 3 | 85 | 2 | 31197031 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 1406710 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12446457 | ||
| Pubmed | Genetic mapping of the murine gene and 14 related sequences encoding chromosomal protein HMG-14. | 2.75e-05 | 24 | 85 | 3 | 1360278 | |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 3.53e-05 | 4 | 85 | 2 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 3.53e-05 | 4 | 85 | 2 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 3.53e-05 | 4 | 85 | 2 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 3.53e-05 | 4 | 85 | 2 | 26098870 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 6160849 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 3.53e-05 | 4 | 85 | 2 | 4745489 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 28957665 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 3.53e-05 | 4 | 85 | 2 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 3.53e-05 | 4 | 85 | 2 | 94264 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 3872721 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 6157477 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 16461340 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 3.53e-05 | 4 | 85 | 2 | 2431276 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12925573 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 16098202 | ||
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 3.53e-05 | 4 | 85 | 2 | 6207174 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9015265 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 30197236 | ||
| Pubmed | Regulation of elongation factor-2 by multisite phosphorylation. | 3.53e-05 | 4 | 85 | 2 | 8386634 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 2410924 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 3.53e-05 | 4 | 85 | 2 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 3.53e-05 | 4 | 85 | 2 | 6163812 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 11846405 | ||
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 3.53e-05 | 4 | 85 | 2 | 2987507 | |
| Pubmed | Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells. | 3.53e-05 | 4 | 85 | 2 | 27058417 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 6091898 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 3.53e-05 | 4 | 85 | 2 | 2332419 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 3.53e-05 | 4 | 85 | 2 | 6162108 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 16152770 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 3.53e-05 | 4 | 85 | 2 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 3.53e-05 | 4 | 85 | 2 | 2989529 | |
| Pubmed | 3.95e-05 | 27 | 85 | 3 | 26544073 | ||
| Pubmed | Phrenic-specific transcriptional programs shape respiratory motor output. | 3.95e-05 | 27 | 85 | 3 | 31944180 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 5.87e-05 | 5 | 85 | 2 | 34276419 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 6176569 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 1348427 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 24931836 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 8640223 | ||
| Pubmed | Calcium-dependent adhesion is necessary for the maintenance of prosomeres. | 5.87e-05 | 5 | 85 | 2 | 11319859 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 23184662 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 5.87e-05 | 5 | 85 | 2 | 8661735 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 12865344 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 10191097 | ||
| Pubmed | Cell binding specificity of mouse R-cadherin and chromosomal mapping of the gene. | 5.87e-05 | 5 | 85 | 2 | 8270638 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 10864459 | ||
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 8.80e-05 | 6 | 85 | 2 | 7859283 | |
| Interaction | CDH7 interactions | 3.72e-06 | 8 | 83 | 3 | int:CDH7 | |
| Interaction | CDH6 interactions | 3.72e-06 | 8 | 83 | 3 | int:CDH6 | |
| Interaction | NAA11 interactions | 5.65e-06 | 62 | 83 | 5 | int:NAA11 | |
| Interaction | CDH9 interactions | 1.44e-05 | 12 | 83 | 3 | int:CDH9 | |
| Interaction | CES3 interactions | 4.39e-05 | 17 | 83 | 3 | int:CES3 | |
| Cytoband | 1p21 | 1.21e-05 | 24 | 85 | 3 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.06e-03 | 107 | 85 | 3 | chr1p21 | |
| Cytoband | 13q14.11 | 2.40e-03 | 39 | 85 | 2 | 13q14.11 | |
| GeneFamily | CD molecules|Type II classical cadherins | 7.87e-06 | 13 | 56 | 3 | 1186 | |
| GeneFamily | CD molecules|Type I classical cadherins | 9.37e-05 | 5 | 56 | 2 | 1185 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.35e-04 | 9 | 56 | 2 | 1280 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 9.64e-04 | 15 | 56 | 2 | 903 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.73e-03 | 20 | 56 | 2 | 736 | |
| GeneFamily | Immunoglobulin like domain containing | 3.00e-03 | 193 | 56 | 4 | 594 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 4.14e-03 | 31 | 56 | 2 | 81 | |
| GeneFamily | Phosphoinositide phosphatases | 4.40e-03 | 32 | 56 | 2 | 1079 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-07 | 143 | 85 | 6 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 155 | 85 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-06 | 180 | 85 | 6 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 187 | 85 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 188 | 85 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 193 | 85 | 6 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.34e-06 | 200 | 85 | 6 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.34e-06 | 200 | 85 | 6 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.34e-06 | 200 | 85 | 6 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.34e-06 | 200 | 85 | 6 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.34e-06 | 200 | 85 | 6 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.34e-06 | 200 | 85 | 6 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-06 | 128 | 85 | 5 | e100629f6038e32176ffcc81bd06bd175df46cef | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.36e-06 | 144 | 85 | 5 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-05 | 152 | 85 | 5 | 18194f757d319958f26e5a91f56d89f25711236f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-05 | 155 | 85 | 5 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.35e-05 | 159 | 85 | 5 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-05 | 160 | 85 | 5 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 161 | 85 | 5 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-05 | 167 | 85 | 5 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-05 | 171 | 85 | 5 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 172 | 85 | 5 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 172 | 85 | 5 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 176 | 85 | 5 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-05 | 177 | 85 | 5 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 178 | 85 | 5 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 179 | 85 | 5 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 179 | 85 | 5 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 179 | 85 | 5 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.39e-05 | 179 | 85 | 5 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-05 | 180 | 85 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-05 | 181 | 85 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 182 | 85 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 182 | 85 | 5 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 182 | 85 | 5 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.66e-05 | 183 | 85 | 5 | bd78e5c2670e67b4363078e3ca5a5b7081d24b7e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-05 | 183 | 85 | 5 | d1bf3abf42eb9d7facf775becf1338d1faadd647 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 184 | 85 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 184 | 85 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 184 | 85 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 186 | 85 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 186 | 85 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 186 | 85 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 2.95e-05 | 187 | 85 | 5 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 187 | 85 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 187 | 85 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.02e-05 | 188 | 85 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 3.18e-05 | 190 | 85 | 5 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 191 | 85 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.42e-05 | 193 | 85 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.42e-05 | 193 | 85 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-05 | 194 | 85 | 5 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 3.51e-05 | 194 | 85 | 5 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 3.60e-05 | 195 | 85 | 5 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.87e-05 | 198 | 85 | 5 | 60d8d3bbd754ffde41c50013d822667b185a9751 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.52e-05 | 121 | 85 | 4 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.79e-05 | 122 | 85 | 4 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.66e-05 | 125 | 85 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.42e-04 | 138 | 85 | 4 | 97f5dc17522462133e582b508ad0ef036e656872 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 148 | 85 | 4 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 148 | 85 | 4 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 148 | 85 | 4 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 150 | 85 | 4 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 150 | 85 | 4 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-04 | 150 | 85 | 4 | 1f83e3be3f94aefe991a3ccd292c2d11ddef858e | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-04 | 150 | 85 | 4 | cd666db614bc1b43d71e8eb7bf38cae4d580be80 | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-04 | 150 | 85 | 4 | f6ed3e7b36014d1e429b255b0027d89865e1ac07 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 151 | 85 | 4 | 3744e4ed87703a97002e001afd16490d525a5128 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-04 | 153 | 85 | 4 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 153 | 85 | 4 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-04 | 154 | 85 | 4 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 154 | 85 | 4 | 391d40ef902773ffe832a50a14d35d31c56d3723 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-04 | 156 | 85 | 4 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 157 | 85 | 4 | 34eb1cbdb023d3e23b2e1695c9c327c21ef1c870 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 157 | 85 | 4 | fc0c222124f59c94d60335f849554eaa4062f8c7 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 157 | 85 | 4 | e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 157 | 85 | 4 | 40b08ace1d9ea7951886f5fed76ac57e9175436b | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 2.38e-04 | 158 | 85 | 4 | 8f66979e92f886d86cecbd26aaa0c5915c049734 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 159 | 85 | 4 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.49e-04 | 160 | 85 | 4 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-04 | 160 | 85 | 4 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.55e-04 | 161 | 85 | 4 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 2.55e-04 | 161 | 85 | 4 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-04 | 163 | 85 | 4 | 9195051d6bcdd450ed745a099828a0d76d9d3f0b | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 164 | 85 | 4 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 164 | 85 | 4 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.00e-04 | 168 | 85 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.14e-04 | 170 | 85 | 4 | 87cac555f16b6c2ef3d1b3a00f992d8bf2237b50 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 170 | 85 | 4 | f3d5678669dcaed1836014cea543758b7ccc6b46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 171 | 85 | 4 | 9d5cabd71a901a00eb16c4d151189296f1b3bf6f | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 171 | 85 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-04 | 173 | 85 | 4 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-04 | 174 | 85 | 4 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-04 | 174 | 85 | 4 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-04 | 174 | 85 | 4 | e9e4532a474b4b0938a50ff85c9508aca53cd3ae | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 3.50e-04 | 175 | 85 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 3.50e-04 | 175 | 85 | 4 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-04 | 175 | 85 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| Drug | AC1N3UXZ | 4.84e-08 | 3 | 84 | 3 | CID004118625 | |
| Drug | CTK2H7378 | 8.34e-08 | 12 | 84 | 4 | CID005462310 | |
| Drug | 2-nitropropyl acetate | 1.93e-07 | 4 | 84 | 3 | CID013573844 | |
| Drug | N-PMT | 1.93e-07 | 4 | 84 | 3 | CID000194224 | |
| Drug | Dembrexine | 1.93e-07 | 4 | 84 | 3 | CID000072009 | |
| Drug | g lw | 1.93e-07 | 4 | 84 | 3 | CID000444139 | |
| Drug | AC1MQT4V | 1.93e-07 | 4 | 84 | 3 | CID003482066 | |
| Drug | beta-santalene | 1.93e-07 | 4 | 84 | 3 | CID000010534 | |
| Drug | SAIB-SG | 1.93e-07 | 4 | 84 | 3 | CID002735139 | |
| Drug | feldspar | 3.03e-07 | 16 | 84 | 4 | CID003080680 | |
| Drug | Bay e 4609 | 3.03e-07 | 16 | 84 | 4 | CID003085308 | |
| Drug | actinidine | 4.82e-07 | 5 | 84 | 3 | CID000068231 | |
| Drug | Deposiston | 4.82e-07 | 5 | 84 | 3 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 4.82e-07 | 5 | 84 | 3 | CID010358258 | |
| Drug | 2TAA | 4.82e-07 | 5 | 84 | 3 | CID000127374 | |
| Drug | cimicifugic acid A | 4.82e-07 | 5 | 84 | 3 | CID006449879 | |
| Drug | silver perchlorate | 4.82e-07 | 5 | 84 | 3 | CID000024562 | |
| Drug | lunularic acid | 4.82e-07 | 5 | 84 | 3 | CID000161413 | |
| Drug | himachalene | 4.82e-07 | 5 | 84 | 3 | CID000015095 | |
| Drug | AC1L4DZ4 | 4.82e-07 | 5 | 84 | 3 | CID000155287 | |
| Drug | sucrose-6-phosphate | 5.07e-07 | 18 | 84 | 4 | CID000644101 | |
| Drug | Lugol's iodine | 6.41e-07 | 19 | 84 | 4 | CID000105053 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 9.61e-07 | 6 | 84 | 3 | CID003083414 | |
| Drug | 2-amino-6-picoline | 9.61e-07 | 6 | 84 | 3 | CID000015765 | |
| Drug | phenol blue | 9.61e-07 | 6 | 84 | 3 | CID000075078 | |
| Drug | R 623 | 9.61e-07 | 6 | 84 | 3 | CID003027594 | |
| Drug | Gu-4 | 9.61e-07 | 6 | 84 | 3 | CID000448679 | |
| Drug | dimethylaminomethylferrocene | 9.61e-07 | 6 | 84 | 3 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 9.61e-07 | 6 | 84 | 3 | CID000127364 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 9.61e-07 | 6 | 84 | 3 | CID009577343 | |
| Drug | Borane dimethylamine complex | 9.61e-07 | 6 | 84 | 3 | CID009898794 | |
| Drug | AC1L3OV4 | 9.61e-07 | 6 | 84 | 3 | CID000092801 | |
| Drug | CNP-G3 | 9.61e-07 | 6 | 84 | 3 | CID003082910 | |
| Drug | AC1OAGH8 | 9.61e-07 | 6 | 84 | 3 | CID006857368 | |
| Drug | vermella | 9.61e-07 | 6 | 84 | 3 | CID000203726 | |
| Drug | hymenin | 9.61e-07 | 6 | 84 | 3 | CID000010499 | |
| Drug | tris(hydroxyethyl)aminomethane | 9.61e-07 | 6 | 84 | 3 | CID000448009 | |
| Drug | mercuric thiocyanate | 9.61e-07 | 6 | 84 | 3 | CID000011615 | |
| Drug | 3KBG5CNP | 1.68e-06 | 7 | 84 | 3 | CID003083250 | |
| Drug | AC1L9UU3 | 1.68e-06 | 7 | 84 | 3 | CID000071762 | |
| Drug | AC1L5BOU | 1.68e-06 | 7 | 84 | 3 | CID000174858 | |
| Drug | Paramax | 1.68e-06 | 7 | 84 | 3 | CID000156411 | |
| Drug | BG5P | 1.68e-06 | 7 | 84 | 3 | CID003082752 | |
| Drug | methyl blue | 1.68e-06 | 7 | 84 | 3 | CID011969534 | |
| Drug | amino-methyl | 1.68e-06 | 7 | 84 | 3 | CID000142005 | |
| Drug | boric acid gel | 2.68e-06 | 8 | 84 | 3 | CID003016474 | |
| Drug | AC1NSVJM | 2.68e-06 | 8 | 84 | 3 | CID005317411 | |
| Drug | theodrenaline | 2.68e-06 | 8 | 84 | 3 | CID000071857 | |
| Drug | N-vinylcaprolactam | 2.68e-06 | 8 | 84 | 3 | CID000075227 | |
| Drug | 9-azidoacridine | 2.68e-06 | 8 | 84 | 3 | CID000146692 | |
| Drug | acrinor | 2.68e-06 | 8 | 84 | 3 | CID005489637 | |
| Drug | Triap | 2.68e-06 | 8 | 84 | 3 | CID000013356 | |
| Drug | rhodanile blue | 2.68e-06 | 8 | 84 | 3 | CID000073372 | |
| Drug | desethylaprophen | 2.68e-06 | 8 | 84 | 3 | CID000163919 | |
| Drug | azintamide | 2.68e-06 | 8 | 84 | 3 | CID000071105 | |
| Drug | NSC300622 | 2.68e-06 | 8 | 84 | 3 | CID000028426 | |
| Drug | AC1LIZYF | 3.07e-06 | 169 | 84 | 7 | CID000914489 | |
| Drug | isoquercitrin | 3.82e-06 | 29 | 84 | 4 | CID005280804 | |
| Drug | R B I | 3.82e-06 | 29 | 84 | 4 | CID003423208 | |
| Drug | Atonik | 4.00e-06 | 9 | 84 | 3 | CID000069471 | |
| Drug | GSAD | 4.00e-06 | 9 | 84 | 3 | CID009909127 | |
| Drug | GU-3 | 4.00e-06 | 9 | 84 | 3 | CID000448687 | |
| Drug | alpha-maltosyl fluoride | 4.00e-06 | 9 | 84 | 3 | CID000194237 | |
| Drug | trestatin A | 4.00e-06 | 9 | 84 | 3 | CID003054994 | |
| Drug | zingiberene | 4.00e-06 | 9 | 84 | 3 | CID000092776 | |
| Drug | H 187 | 4.00e-06 | 9 | 84 | 3 | CID000001742 | |
| Drug | mercuric nitrate | 4.00e-06 | 9 | 84 | 3 | CID000024864 | |
| Drug | AC1LAC07 | 5.71e-06 | 10 | 84 | 3 | CID000485275 | |
| Drug | I ZE | 5.71e-06 | 10 | 84 | 3 | CID009549200 | |
| Drug | Glc)4 | 5.71e-06 | 10 | 84 | 3 | CID000189098 | |
| Drug | trans-cinnamamide | 5.71e-06 | 10 | 84 | 3 | CID000012135 | |
| Drug | CG-120 | 5.71e-06 | 10 | 84 | 3 | CID000171403 | |
| Drug | Ro 20-0083 | 5.71e-06 | 10 | 84 | 3 | CID003082332 | |
| Drug | naphthalene-1,3,6,8-tetrol | 5.71e-06 | 10 | 84 | 3 | CID000440202 | |
| Drug | AC1L3M0Q | 5.71e-06 | 10 | 84 | 3 | CID000118008 | |
| Drug | eicosa-11,14-dienoic acid | 5.71e-06 | 10 | 84 | 3 | CID000003208 | |
| Drug | UDP-pyridoxal | 5.71e-06 | 10 | 84 | 3 | CID000126789 | |
| Drug | validamycin D | 7.82e-06 | 11 | 84 | 3 | CID000166726 | |
| Drug | AMO-1618 | 7.82e-06 | 11 | 84 | 3 | CID000017103 | |
| Drug | FG5P | 7.82e-06 | 11 | 84 | 3 | CID000127486 | |
| Drug | AC1L8PXO | 7.82e-06 | 11 | 84 | 3 | CID000430710 | |
| Drug | CNP-G5 | 7.82e-06 | 11 | 84 | 3 | CID000127309 | |
| Drug | Tempamine | 7.82e-06 | 11 | 84 | 3 | CID000550942 | |
| Drug | HgI2 | 7.82e-06 | 11 | 84 | 3 | CID000024485 | |
| Drug | L-tert-leucine | 7.82e-06 | 11 | 84 | 3 | CID000164608 | |
| Drug | 2C KM | 7.82e-06 | 11 | 84 | 3 | CID009549196 | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 2816_DN | |
| Drug | chitosan | 1.04e-05 | 12 | 84 | 3 | CID000071853 | |
| Drug | azaprophen | 1.04e-05 | 12 | 84 | 3 | CID000129486 | |
| Drug | Avenin | 1.04e-05 | 12 | 84 | 3 | CID000095924 | |
| Drug | AC1L4W0B | 1.04e-05 | 12 | 84 | 3 | CID000193311 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 1.04e-05 | 12 | 84 | 3 | CID000072699 | |
| Drug | H2folate | 1.04e-05 | 12 | 84 | 3 | CID000168809 | |
| Drug | chloroisocyanuric acid | 1.04e-05 | 12 | 84 | 3 | CID000017921 | |
| Drug | glyciphosphoramide | 1.04e-05 | 12 | 84 | 3 | CID000197092 | |
| Drug | GA15 | 1.35e-05 | 13 | 84 | 3 | CID000443453 | |
| Drug | dibromopropanol | 1.35e-05 | 13 | 84 | 3 | CID000007281 | |
| Drug | AC1L9AGE | 1.35e-05 | 13 | 84 | 3 | CID000441043 | |
| Drug | AC1NTMU5 | 1.35e-05 | 13 | 84 | 3 | CID003035508 | |
| Drug | 8a-c | 1.35e-05 | 13 | 84 | 3 | CID000066085 | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 2.16e-04 | 8 | 83 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | alpha-amylase 1 measurement | 2.78e-04 | 9 | 83 | 2 | EFO_0801371 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 5.98e-04 | 13 | 83 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 1.76e-03 | 616 | 83 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.76e-03 | 616 | 83 | 7 | C0376358 | |
| Disease | lung adenocarcinoma (is_marker_for) | 1.80e-03 | 85 | 83 | 3 | DOID:3910 (is_marker_for) | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.07e-03 | 24 | 83 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 2.43e-03 | 26 | 83 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPDAKGDDAWKVYYD | 841 | Q9UPW8 | |
| KDYVFKELQRDWPGY | 261 | O00472 | |
| YKDVQKDWPGYSEGD | 266 | P55199 | |
| PGKYTYLFNEWRSEE | 586 | Q75V66 | |
| WAPDFYVVTYTGDKE | 771 | Q8TDI0 | |
| DPRGYNWYKGETVDA | 61 | P31997 | |
| SYRWPRYFENGKDVN | 356 | P0DTE7 | |
| SYRWPRYFENGKDVN | 356 | P0DTE8 | |
| VDRYFTRWYKPDVKG | 16 | Q9NX38 | |
| GFDYGDRFWDIKSKY | 1151 | Q96KQ7 | |
| SYRWPRYFENGKDVN | 356 | P0DUB6 | |
| WNDFAYIEVDGKKYP | 1226 | Q8WUJ3 | |
| TEPWKEKFFERFYGE | 346 | Q9C0F0 | |
| GWKVYDPVSEYKRQG | 226 | Q13613 | |
| SGGPKYEYRWQDDLK | 91 | Q86TA1 | |
| KNTQRKDPYYGADWG | 201 | Q7Z3D4 | |
| RFWNYNKSPEDTYRG | 1311 | O60303 | |
| YWTYPDDEKRKNPIG | 1016 | Q9NQW6 | |
| GSQDFYPKWRESKLF | 856 | Q9NR82 | |
| RYTKNWETNKFSGYP | 536 | Q04609 | |
| EYKEVFPENGWKLYD | 196 | Q13614 | |
| EEGRKGNKLYYNFPW | 281 | Q9UHN1 | |
| GTPYDPYKALWFERK | 761 | P22059 | |
| LPDWAAAKEFYQKYD | 11 | P15735 | |
| VYAGWKDFIYGEPRK | 226 | A6NCF6 | |
| YLNAKKWRVGDDPYK | 61 | Q96FL9 | |
| KWRVGDDPYKLYAFN | 66 | Q96FL9 | |
| DWKTFEKNARYEPGY | 916 | Q9UII4 | |
| EGYKEAEYWLRKFEA | 261 | Q8TCG2 | |
| AYFPSWVVSKRGKDY | 181 | Q96NE9 | |
| PYYKGFEDKVSIWER | 1316 | Q8NCM8 | |
| ENFVYNDDEPFKPWK | 341 | Q8IUX4 | |
| DYGTKAYEWEKAGRS | 2096 | Q13535 | |
| TYEDRPSKAPSFWYK | 321 | P40189 | |
| PVVNVDGYDYSWKKN | 221 | Q96IY4 | |
| EKGGTKYNWDPSVYD | 186 | O75398 | |
| QDYDYLNDWGPRFKK | 891 | P55283 | |
| YYDNEKCWFGKRPGV | 281 | P34998 | |
| NDPGWIKTFDKYYTE | 176 | P49641 | |
| YWEDYRQFCKTTAKP | 141 | Q8NCS7 | |
| DQDYDYLSDWGPRFK | 761 | P55285 | |
| WKGASNYVAKRYIEP | 161 | O00418 | |
| WGDRYFDPANGKFSK | 261 | P13639 | |
| DFVASKGFPWDEYKL | 601 | Q9UNN5 | |
| YPKGTISKDNSWRFY | 6446 | Q8NDH2 | |
| DQNYDYLSDWGPRFK | 756 | Q9ULB5 | |
| VNYTWYGDKRPFPKE | 161 | P09326 | |
| NQDYDYLSDWGPRFK | 761 | Q9ULB4 | |
| EQDYDYLNDWGPRFK | 881 | P19022 | |
| EWRDPDKYCPSYNKS | 31 | Q96FZ2 | |
| YKYWPDDTEVYGDFK | 996 | Q15262 | |
| DPFANKDDPFYYDWK | 21 | P59646 | |
| TGEWFYEERAKKFPT | 116 | Q4VX76 | |
| LKDVFERDWYSPYAK | 486 | Q8N7P1 | |
| FFVQWSPDVYGKDAK | 706 | Q8NI08 | |
| FGIESWPDYEDIYKK | 266 | Q53T94 | |
| KDPWNLSNDEYYFPK | 581 | Q8IZX4 | |
| DVDYEKNAKGSNYWR | 266 | P30101 | |
| EEKENAWEGGKYKYP | 466 | Q9ULN7 | |
| WPDGYVRFIYSSDEK | 41 | O75603 | |
| EQKSFLGPRKDYWDF | 56 | Q6ZNE9 | |
| FKSEPRWDFEEKYSF | 256 | Q9NSC7 | |
| DQGPWYLAFYNDGKK | 501 | Q9UKZ4 | |
| YEYQPFAGKIKDIAW | 96 | O75083 | |
| FEGPYKEYHEEAQKW | 341 | Q9C0C4 | |
| YWRFTNDIKDAGYPK | 1216 | Q92954 | |
| EFGWPLEKAYNYVKQ | 411 | Q8WYL5 | |
| YGSLIWKVDFPYQDK | 6 | Q8WUX2 | |
| EGTKIYKDSWDFEPY | 321 | Q9Y471 | |
| NEWKLPKDTYYDFDA | 1291 | Q7KZ85 | |
| GKYYEPKQLFWNSDC | 1431 | O75443 | |
| KVAEPAEYLKYGAWD | 426 | Q92618 | |
| FDFSYFKGPELWESK | 56 | Q12768 | |
| QYKKRYKDWEDPNGE | 2766 | Q8IZQ1 | |
| WRTYREYFGEKTDPK | 71 | Q96DV4 | |
| YFKGKWNEPFDETYT | 166 | P50453 | |
| KWKPDYDSAASEYGK | 26 | Q99747 | |
| WLKEPYFVQAVDYGD | 216 | Q9H2E6 | |
| YYNTETGESRWEKPD | 181 | O75554 | |
| DWTDTNYYSEKGFPK | 161 | O43657 | |
| RYGVTDKNPAGDYWK | 1336 | O15040 | |
| PGYSAWIKEEAAERY | 596 | Q9H1V8 | |
| WRKPSEEFNGYLYKA | 41 | Q96DR4 | |
| WSDLDPTQKEFYGEY | 251 | O95125 | |
| DKPYKYNECGEAFLW | 651 | Q8N7M2 | |
| NEDKWRGKVSYQDYE | 116 | P20591 |